262 related articles for article (PubMed ID: 19287004)
1. JAK2 and SHP2 reciprocally regulate tyrosine phosphorylation and stability of proapoptotic protein ASK1.
Yu L; Min W; He Y; Qin L; Zhang H; Bennett AM; Chen H
J Biol Chem; 2009 May; 284(20):13481-13488. PubMed ID: 19287004
[TBL] [Abstract][Full Text] [Related]
2. SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation.
He Y; Zhang W; Zhang R; Zhang H; Min W
J Biol Chem; 2006 Mar; 281(9):5559-66. PubMed ID: 16407264
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY
Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672
[TBL] [Abstract][Full Text] [Related]
4. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.
Waiboci LW; Ahmed CM; Mujtaba MG; Flowers LO; Martin JP; Haider MI; Johnson HM
J Immunol; 2007 Apr; 178(8):5058-68. PubMed ID: 17404288
[TBL] [Abstract][Full Text] [Related]
5. AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation.
Min W; Lin Y; Tang S; Yu L; Zhang H; Wan T; Luhn T; Fu H; Chen H
Circ Res; 2008 Apr; 102(7):840-8. PubMed ID: 18292600
[TBL] [Abstract][Full Text] [Related]
6. RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation.
Zhang H; Zhang H; Lin Y; Li J; Pober JS; Min W
J Biol Chem; 2007 May; 282(20):14788-96. PubMed ID: 17389591
[TBL] [Abstract][Full Text] [Related]
7. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
[TBL] [Abstract][Full Text] [Related]
9. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells.
Monni R; Santos SC; Mauchauffe M; Berger R; Ghysdael J; Gouilleux F; Gisselbrecht S; Bernard O; Penard-Lacronique V
Oncogene; 2001 Feb; 20(7):849-58. PubMed ID: 11314018
[TBL] [Abstract][Full Text] [Related]
10. SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor.
Ali S; Nouhi Z; Chughtai N; Ali S
J Biol Chem; 2003 Dec; 278(52):52021-31. PubMed ID: 14522994
[TBL] [Abstract][Full Text] [Related]
11. Autophagy facilitates IFN-gamma-induced Jak2-STAT1 activation and cellular inflammation.
Chang YP; Tsai CC; Huang WC; Wang CY; Chen CL; Lin YS; Kai JI; Hsieh CY; Cheng YL; Choi PC; Chen SH; Chang SP; Liu HS; Lin CF
J Biol Chem; 2010 Sep; 285(37):28715-22. PubMed ID: 20592027
[TBL] [Abstract][Full Text] [Related]
12. Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway.
Funakoshi-Tago M; Nagata T; Tago K; Tsukada M; Tanaka K; Nakamura S; Mashino T; Kasahara T
Cell Signal; 2012 Nov; 24(11):2024-34. PubMed ID: 22750290
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IFN-gamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2.
Baron M; Davignon JL
J Immunol; 2008 Oct; 181(8):5530-6. PubMed ID: 18832710
[TBL] [Abstract][Full Text] [Related]
14. The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis.
Zehender A; Huang J; Györfi AH; Matei AE; Trinh-Minh T; Xu X; Li YN; Chen CW; Lin J; Dees C; Beyer C; Gelse K; Zhang ZY; Bergmann C; Ramming A; Birchmeier W; Distler O; Schett G; Distler JHW
Nat Commun; 2018 Aug; 9(1):3259. PubMed ID: 30108215
[TBL] [Abstract][Full Text] [Related]
15. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells.
McPherson VA; Sharma N; Everingham S; Smith J; Zhu HH; Feng GS; Craig AW
J Immunol; 2009 Oct; 183(8):4940-7. PubMed ID: 19786542
[TBL] [Abstract][Full Text] [Related]
16. Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase.
Perrinjaquet M; Vilar M; Ibáñez CF
J Biol Chem; 2010 Oct; 285(41):31867-75. PubMed ID: 20682772
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1.
Ungureanu D; Saharinen P; Junttila I; Hilton DJ; Silvennoinen O
Mol Cell Biol; 2002 May; 22(10):3316-26. PubMed ID: 11971965
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function.
Flowers LO; Johnson HM; Mujtaba MG; Ellis MR; Haider SM; Subramaniam PS
J Immunol; 2004 Jun; 172(12):7510-8. PubMed ID: 15187130
[TBL] [Abstract][Full Text] [Related]
19. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses.
Kohlhuber F; Rogers NC; Watling D; Feng J; Guschin D; Briscoe J; Witthuhn BA; Kotenko SV; Pestka S; Stark GR; Ihle JN; Kerr IM
Mol Cell Biol; 1997 Feb; 17(2):695-706. PubMed ID: 9001223
[TBL] [Abstract][Full Text] [Related]
20. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.
Schmitz J; Weissenbach M; Haan S; Heinrich PC; Schaper F
J Biol Chem; 2000 Apr; 275(17):12848-56. PubMed ID: 10777583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]